1. Home
  2. GOSS vs HIFS Comparison

GOSS vs HIFS Comparison

Compare GOSS & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.44

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo Hingham Institution for Savings

HIFS

Hingham Institution for Savings

HOLD

Current Price

$268.42

Market Cap

682.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
HIFS
Founded
2015
1834
Country
United States
United States
Employees
145
92
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
682.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GOSS
HIFS
Price
$0.44
$268.42
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$4.91
N/A
AVG Volume (30 Days)
26.7M
46.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.92%
EPS Growth
78.81
N/A
EPS
N/A
N/A
Revenue
$114,701,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.63
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$209.71
52 Week High
$3.87
$338.00

Technical Indicators

Market Signals
Indicator
GOSS
HIFS
Relative Strength Index (RSI) 22.21 36.77
Support Level $0.33 $258.88
Resistance Level $0.60 $297.56
Average True Range (ATR) 0.06 12.47
MACD 0.04 -2.13
Stochastic Oscillator 45.47 11.00

Price Performance

Historical Comparison
GOSS
HIFS

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About HIFS Hingham Institution for Savings

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

Share on Social Networks: